Recent Development of Supramolecular Cancer Theranostics Based on Cyclodextrins: A Review
Molecules · 13.04.2023 · 28 (8) · 3441
DOI: 10.3390/molecules28083441 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 13.04.2023. Verfasst von Wenting Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China. Hauptthemen laut MEDLINE: Cyclodextrins, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Zhejiang Province, Zhejiang High-Level Young Talent Special Support Plan.
Abstract (Originalsprache)
With the development of personalized medical demands for precise diagnosis, rational management and effective cancer treatment, supramolecular theranostic systems have received widespread attention due to their reversibly switchable structures, sensitive response to biological stimuli and integration ability for multiple capabilities in a single platform with a programmable fashion. Cyclodextrins (CDs), benefiting from their excellent characteristics, such as non-toxicity, easy modification, unique host–guest properties, good biocompatibility, etc., as building blocks, serve as an all-purpose strategy for the fabrication of a supramolecular cancer theranostics nanodevice that is capable of biosafety, controllability, functionality and programmability. This review focuses on the supramolecular systems of CD-bioimaging probes, CD-drugs, CD-genes, CD-proteins, CD-photosensitizers and CD-photothermal agents as well as multicomponent cooperation systems with regards to building a nanodevice with functions of diagnosis and (or) therapeutics of cancer treatment. By introducing several state-of-the-art examples, emphasis will be placed on the design of various functional modules, the supramolecular interaction strategies under the fantastic topological structures and the hidden “bridge” between their structures and therapeutic efficacy, aiming for further comprehension of the important role of a cyclodextrin-based nanoplatform in advancing supramolecular cancer theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
- Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou 310009, China.
- Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou 310009, China.
- Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease, Zhejiang University, Hangzhou 310009, China.
- Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou 310009, China.
- Cancer Center, Zhejiang University, Hangzhou 310009, China.
ORCID-Profile: Zhengwei Mao
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Zhejiang Province
- Zhejiang High-Level Young Talent Special Support Plan
- National Key Research and Development Program of China
Zitieren
APA
Hu, W., Ye, B., Yu, G., Huang, F., Mao, Z., Ding, Y., & Wang, W. (2023). Recent Development of Supramolecular Cancer Theranostics Based on Cyclodextrins: A Review. Molecules, 28(8), 3441. https://doi.org/10.3390/molecules28083441
Vancouver
Hu W, Ye B, Yu G, Huang F, Mao Z, Ding Y, et al. Recent Development of Supramolecular Cancer Theranostics Based on Cyclodextrins: A Review. Molecules. 2023;28(8):3441. doi:10.3390/molecules28083441
BibTeX
@article{Hu2023,
author = {Hu, Wenting and Ye, Binglin and Yu, Guocan and Huang, Feihe and Mao, Zhengwei and Ding, Yuan and Wang, Weilin},
title = {Recent Development of Supramolecular Cancer Theranostics Based on Cyclodextrins: A Review},
journal = {Molecules},
year = {2023},
volume = {28},
number = {8},
pages = {3441},
doi = {10.3390/molecules28083441}
}
EUVIMED